Menu ×

HEALTHCARE & PHARMACEUTICAL

Testosterone Injectable Market Segmentation by Dosage Form (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, and Others); by Age Group (Adults, Geriatric, and Pediatric); and by End User (Hospitals, Homecare, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Testosterone Injectable Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • January 2022- Endo announced the publication of data from a population pharmacokinetic (PK) modeling and simulation study, evaluating potential dosing flexibility of AVEED, a testosterone undecanoate, in hypogonadal males.

  • June 2021- Novartis unveiled that 177Lu-PSMA-617 improved overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer

Global Testosterone Injectable Market Highlights Over 2022 - 2031

The global testosterone injectable market is estimated to garner a substantial revenue by growing at a CAGR of ~4% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed primarily to the rapidly growing geriatric population across the world, and their high risk of testosterone deficiency. According to the World Health Organization (WHO), the percentage of the world’s population over 60 years and above will nearly double from 12% to 22%. It is evaluated that 1 in 6 people globally will be aged 60 years or over by 2030. Along with these, increasing prevalence of testosterone deficiency and hormonal imbalance disorders, and rising awareness levels about testosterone injectables globally are also expected to accelerate the growth of the market in the forthcoming years. Furthermore, advancements in healthcare infrastructure around the world, and improved access to a wide range of diagnostic and treatment services are projected to offer ample growth opportunities to the market in the near future.

Testosterone Injectable Market Graph

The market is segmented by dosage form into hypogonadism, autoimmune conditions, genetic disorders, sex organ surgeries, and others, out of which, the hypogonadism segment is anticipated to hold the largest share in the global testosterone injectable market. This can be accounted to the high utilization of testosterone injectables to bring testosterone levels to normal in male hypogonadism cases. Apart from this, rising number of incidences of the disease around the world is also predicted to boost the growth of the market segment in the future. Additionally, on the basis of end user, the hospitals segment is assessed to occupy the largest share during the forecast period owing to the availability of sophisticated medical equipment, and high preference of patients to get treatment from a hospital facility.CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Testosterone Injectable Market Regional Synopsis

Regionally, the global testosterone injectable market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in North America is estimated to grab the largest share and witness noteworthy growth over the forecast period on the back of the increasing occurrence of hypogonadism, and high availability of testosterone injectables in the region. In addition, high healthcare expenditure, especially in the United States, is also expected to fuel the market growth in the region in the coming years. As per the Centers for Medicare & Medicaid Services (CMS), the healthcare spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion. As a share of the nation’s Gross Domestic Product (GDP), the health spending accounted for about 19.7%. Moreover, the market in Europe is also projected acquire a notable share during the forecast period ascribing to the escalating geriatric population, and well-established healthcare infrastructure in the region.

Testosterone Injectable Market Share Graph

The global testosterone injectable market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global testosterone injectable market includes the following segments:

By Dosage Form

  • Hypogonadism
  • Autoimmune Conditions
  • Genetic Disorders
  • Sex Organ Surgeries
  • Others

By Age Group

  • Adults
  • Geriatric
  • Pediatric

By End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Growth Drivers

  • Rapidly Growing Geriatric Population Across the World
  • High Risk of Testosterone Deficiency Among People Globally

Challenges

  • Side Effects Associated with Testosterone Injectables

Top Featured Companies Dominating the Market

  • Bayer AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Endo Pharmaceuticals Inc.
  • Eli Lilly & Company
  • Kyowa Kirin International plc
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Allergan Plc
  • AbbVie Inc.
  • Longyan Tianhua Biological Technology Co. Ltd

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved